SCHEMBL7134452

SCHEMBL7134452

C(#Cc1ccccc1)C1=C/C=C\C=C/C=C\1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.52
MAPT P10636 2/20 0.41
GRM5 P41594 7/20 0.39
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
NPC1 O15118 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 1/20 0.38
KCNH2 Q12809 1/20 0.36
THPO P40225 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7134455 1.00 APP (0.52) APPMAPTGRM5CYP1A2CYP3A4
Diphenylacetylene SCHEMBL29188592 0.72 APP (1.00) APPMAPTGRM5CYP1A2CYP3A4
Diphenylacetylene SCHEMBL960609 0.72 APP (1.00) APPMAPTGRM5CYP1A2CYP3A4
Diphenylacetylene SCHEMBL68254 0.72 APP (1.00) APPMAPTGRM5CYP1A2CYP3A4
SCHEMBL4260946 0.69 APP (0.46) APPMAPTGRM5CYP1A2CYP3A4
SCHEMBL5169115 0.69 APP (0.46) APPMAPTGRM5CYP1A2CYP3A4
Diphenylacetylene SCHEMBL23754282 0.69 APP (0.92) APPMAPTGRM5CYP1A2CYP3A4
Diphenylacetylene SCHEMBL9273707 0.69 APP (0.92) APPMAPTGRM5CYP1A2CYP3A4
Diphenylacetylene SCHEMBL31286315 0.69 APP (0.92) APPMAPTGRM5CYP1A2CYP3A4
Diphenylacetylene SCHEMBL5576302 0.69 APP (0.92) APPMAPTGRM5CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506505-B1 For use in a larger display, a vehicle, a computer, a television, a printer, a large area wall, theater or stadium screen, a billboard and a sign THE UNIVERSITY OF SOUTHERN CALIFORNIA 2003-01-14 US disclosed
US-6350875-B1 COMPOUNDS FOR ELECTRONICS THE UNIVERSITY OF SOUTHERN CALIFORNIA 2002-02-26 US disclosed
US-20020016474-A1 Synthesis of cyclooctatetraene derivatives and their use as electron transporters in organic light emitting diodes WEBER WILLIAM P (US) 2002-02-07 US disclosed
WO-2001013683-A1 CYCLOOCTATETRAENES AS ELECTRON TRANSPORTERS IN ORGANIC LIGHT EMITTING DIODES THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2001-02-22 WO disclosed
WO-2001012576-A1 SYNTHESIS OF CYCLOOCTATETRAENE DERIVATIVES AND THEIR USE AS ELECTRON TRANSPORTERS IN ORGANIC LIGHT EMITTING DIODES THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2001-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016474-A1 Synthesis of cyclooctatetraene derivatives and their use as electron transporters in organic light emitting diodes SLC18A3, SLC18A2, SLC25A21 APP 4212/4885MAPT 614/4885GRM5 1823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.